Expression and characterization of a low molecular weight recombinant human gelatin: Development of a substitute for animal-derived gelatin with superior features

Protein Expression and Purification

Volumn 40, Issue 2, 2005, Pages 346-357

  Olsen, David ^a   Jiang, Jenny ^a   Chang, Robert ^a   Duffy, Robert ^a   Sakaguchi, Masahiro ^b   Leigh, Scott ^a   Lundgard, Robert ^a   Ju, Julia ^a   Buschman, Frank ^a   Truong Le, Vu ^c   Pham, Binh ^c   Polarek, James W ^a  

^a FIBROGEN INC   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c MEDIMMUNE   (United States)

Author keywords

Cation exchange chromatography; Gelatin; Phosphorylation; Pichia pastoris; Recombinant; Vaccine stabilizer

Indexed keywords

EID: 20044377203     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.11.016     Document Type: Article

References (34)

1. C.J. Burke, T-A. Hsu, and D.B. Volkin Formulation, stability, and delivery of live attenuated vaccines for human use Crit. Rev. Ther. Drug Carrier Systems 16 1999 1 83
2. th ed., Medical Economic Company, Inc, Montvale, New Jersey, 2000
3. A. Asghar, and R.L. Henrickson Chemical, biochemical, functional, and nutritional characteristics of collagen in food systems Adv. Food Res. 28 1982 231 372
4. Y. Sakai, R. Yamato, M. Onuma, T. Kikuta, M. Watanabe, and T. Nakayama Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix Biol. Pharm. Bull. 21 1998 330 334
5. J.M. Saddler, and P.J. Horsey The new generation gelatins. A review of their history, manufacture and properties Anesthesiology 42 1987 998 1004
6. D.M. Asher The transmissible spongiform encephalopathy agents: concerns and response of the United States regulatory agencies on the origin Dev. Biol. Stand. 100 1999 103 118
7. M. Sakaguchi, and S. Inouye Systemic allergic reactions to gelatin included in vaccines as a stabilizer Jpn. J. Infect. Dis. 53 2000 189 195
8. J.M. Kelso The gelatin story Allergy Clin. Immunol. 103 1999 200 202
9. T. Kumagai, Y. Yamanaka, Y. Wataya, A. Umetsu, N. Kawamura, K. Ikeda, H. Furukawa, K. Kimura, S. Chiba, S. Saito, N. Sugawara, F. Kurimoto, M. Dakaguchi, and S. Inouye Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines J. Allergy Clin. Immunol. 100 1997 130 134
10. J.M. Kelso, R.T. Jones, and J.W. Yunginger Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin J. Allergy Clin. Immunol. 91 1993 867 872
11. M. Sakaguchi, H. Ogura, and S. Inouye Measurement of IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines J. Allergy Clin. Immunol. 96 1995 563 565
12. M. Sakaguchi, H. Hori, S. Hattori, S. Irie, A. Imai, M. Yanagida, H. Miyazawa, M. Toda, and S. Inouye IgE reactivity to α1 and α 2 chains of bovine type I collagen in children with bovine gelatin allergy J. Allergy Clin. Immunol. 104 1999 669 695
13. H. Hori, S. Hattori, S. Inouye, A. Kimura, S. Irie, H. Miyazawa, and M. Sakaguchi Analysis of the major epitope of the α2 chain of bovine type I collagen in children with bovine gelatin allergy J. Allergy Clin. Immunol. 110 2002 652 657
14. E.H. Wegner, Biochemical conversions by yeast fermentation at highcell densities, 1983, U.S. Patent 4414329
15. J.M. Cregg, T.S. Vedick, and W.C. Raschke Recent advances in the expression of foreign genes in Pichia pastoris Bio/Technol 11 1993 905 910
16. D. Olsen, C. Yang, M. Bodo, R. Chang, S. Leigh, J. Baez, D. Carmichael, and M. Perala E-R. Hamalainen, M. Jarvinen, J. Polarek, Recombinant collagen and gelatin for drug delivery Adv. Drug Delivery Rev. 55 2003 1547 1567
17. G. Tromp, H. Kuivaniemi, A. Stacey, H. Shikata, C.T. Baldwin, R. Jaenisch, and D.J. Prockop Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen Biochem. J. 253 1988 919 922
18. R.J. Butkowski, M.E. Noelken, and B.G. Hudson B.G. Estimation of the size of collagenous proteins by electrophoresis and gel chromatography Methods Enzymol. 82 1982 410 423
19. M. Nokelainen, H. Tu, A. Vuorela, H. Notbohm, K.I. Kivirikko, and J. Myllyharju High-level production of human type I collagen in the yeast Pichia pastoris Yeast 18 2001 797 806
20. G. Teshima, J.T. Stults, V. Ling, and E. Canova-Davis Isolation and characterization of a succinimide variant of methionyl human growth hormone J. Biol. Chem. 266 1991 13544 13547
21. T. Geiger, and S. Clarke Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation J. Biol. Chem. 262 1987 785 794
22. T. Hunter Protein kinases Methods Enzymol. 200 1991 3 9
23. M.W.T. Werten, T.J. van den Bosch, R.D. Wind, H. Mooibroek, and F.A. de Wolf High-yield secretion of recombinant gelatins by Pichia pastoris Yeast 15 1999 1087 1096
24. T. Boehm, S. Pirie-Shepherd, L-B. Trinh, J. Shiloach, and J. Folkman Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin Yeast 15 1999 563 572
25. K. Gelse, E. Poschl, and T. Aigner Collagens-structure, function, and biosynthesis Adv. Drug Delivery Rev. 55 2003 1531 1546
26. D. Horlein, P. Fietzek, E. Wachter, C.M. Lapiere, and K. Kuhn Amino acid sequence of the aminoterminal segment of dermatosparatic calf-skin procollagen type I Eur. J. Biochem. 99 1979 31 38
27. M.W.T. Werten, W.H. Wisselink, T.J. Jansen-van den Bosch, E.C. de Bruin, and F.A. de Wolf Secreted production of a custom-designed, highly hydrophilic gelatin in Pichia pastoris Protein Eng. 14 2001 447 454
28. S. Mochizuki, N. Hamato, M. Hirose, K. Miyano, W. Ohtani, S. Kameyama, S. Kuwae, T. Tokuyama, and H. Ohi Expression and characterization of recombinant human antithrombin III in Pichia pastoris Protein Expr. Purif. 23 2001 55 65
29. Y. Asami, H. Nagano, S. Ikematsu, and A. Murasugi An approach to the removal of yeast specific O-linked oligomannose from human midkine expressed in Pichia pastoris using site-specific mutagenesis J. Biochem. (Tokyo) 128 2000 823 826
30. M.C. Bewley, B.M. Tam, J. Grewal, S. He, S. Shewry, M.E. Murphy, A.B. Mason, R.C. Woodworth, E.N. Baker, and R.T.A. MacGillivray X-ray crystallography and mass spectroscopy reveal that the N-lobe of human transferring expressed in Pichia pastoris is folded correctly but is glycosylated on serine-32 Biochemistry 38 1999 2535 2541
31. J.M. O'Leary, C.M. Radcliffe, A.C. Willis, R.A. Dwek, P.M. Rudd, and A.K. Downing Identification and removal of O-linked and non-covalently linked sugars from recombinant protein produced using Pichia pastoris Protein Exp. Purif. Epub. 2004
32. D.B. Volkin, C.J. Burke, G. Sanyal, and C.R. Middaugh Analysis of vaccine stability Dev. Biol. Stand. 87 1996 135 142
33. B. Fanget, and A. Francon A varicella vaccine stabile at 5°C Dev. Biol. Stand. 87 1996 167 171
34. E. deRizzo, E.C. Tenorio, I.F. Mendes, F.L. Fang, M.M. Pral, C.S. Takata, C. Miyaki, N.M. Gallina, H.N. Tuchiya, and O.K. Akimura Sorbitol-gelatin and glutamic-lactose solutions for stabilization of reference preparations of measles virus Bull. Pan. Am. Health Organ. 23 1989 299 305